Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma
- 19 September 2005
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 97 (1), 98-108
- https://doi.org/10.1002/jcb.20621
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Regulation of apoptosis by endoplasmic reticulum pathwaysOncogene, 2003
- Bcl-2 expression in pancreas development and pancreatic cancer progressionThe Journal of Pathology, 2001
- Detailed Tissue Expression of bcl-2, bax, bak and bcl-x in the Normal Human Pancreas and in Chronic Pancreatitis, Ampullary and Pancreatic Ductal AdenocarcinomasPancreatology, 2001
- Insulin-like Growth Factor-binding Protein-3 Modulates Expression of Bax and Bcl-2 and Potentiates p53-independent Radiation-induced Apoptosis in Human Breast Cancer CellsPublished by Elsevier BV ,2000
- p53 Suppresses the Activation of the Bcl-2 Promoter by the Brn-3a POU Family Transcription FactorPublished by Elsevier BV ,1999
- bax, but notbcl-2, influences the prognosis of human pancreatic cancerGut, 1998
- Analysis of p53, p21WAF1, and TGF-β1 in Human Ductal Adenocarcinoma of the Pancreas: TGF-β1 Protein Expression Predicts Longer SurvivalAmerican Journal of Clinical Pathology, 1998
- Growth factor modulation of p53-mediated growth arrest versus apoptosis.Published by Cold Spring Harbor Laboratory ,1995
- Thymocyte apoptosis induced by p53-dependent and independent pathwaysNature, 1993
- Prognostic indicators for survival after resection of pancreatic adenocarcinomaThe American Journal of Surgery, 1993